Convergence Investment Partners’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.07M Buy
111,569
+41,953
+60% +$2.04M 0.58% 52
2026
Q1
$2.99M Buy
69,616
+21,324
+44% +$917K 0.49% 62
2025
Q4
$2.12M Buy
+48,292
New +$2M 0.42% 72
2025
Q3
Sell
-38,111
Closed -$1.68M 264
2025
Q2
$1.68M Buy
38,111
+1,105
+3% +$44.2K 0.43% 78
2025
Q1
$1.37M Buy
37,006
+13,518
+58% +$482K 0.38% 88
2024
Q4
$782K Buy
+23,488
New +$762K 0.17% 167
2017
Q2
Sell
-93,352
Closed -$2.02M 359
2017
Q1
$2.02M Sell
93,352
-24,385
-21% -$496K 0.28% 132
2016
Q4
$1.75M Buy
117,737
+80,577
+217% +$1.16M 0.24% 159
2016
Q3
$475K Buy
+37,160
New +$402K 0.07% 290

Other funds holding EXEL

Convergence Investment Partners's EXEL Position: Q2 2026 in Review

Convergence Investment Partners increased its Exelixis (EXEL) stake by 60% in Q2 2026, buying an estimated $2.04M and bringing the position to 111,569 shares worth $6.07M. The position accounts for 0.58% of the portfolio, ranked #52.

Convergence Investment Partners first reported a position in EXEL in Q3 2016 and has held it in 9 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Convergence Investment Partners held 111,569 shares of Exelixis worth $6.07M as of Q2 2026.
  • Convergence Investment Partners bought 41,953 Exelixis shares in Q2 2026, an estimated $2.04M.
  • Exelixis made up 0.58% of Convergence Investment Partners's portfolio in Q2 2026, its #52 holding.
  • Convergence Investment Partners first reported a position in Exelixis in Q3 2016 and has held it in 9 quarters since.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Convergence Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.